## **Core Concept**
The patient's symptoms, including pain in fingers on exposure to cold, arthralgias, and difficulty swallowing solid food, are suggestive of **Systemic Sclerosis (Scleroderma)**, a chronic autoimmune disorder characterized by fibrosis and thickening of the skin and involvement of internal organs.

## **Why the Correct Answer is Right**
The correct answer, **Antinuclear Antibody (ANA) test**, is the most useful initial test for diagnosing Systemic Sclerosis. A positive ANA test is found in more than 95% of patients with scleroderma, making it a sensitive marker for the disease. While not specific for scleroderma, a positive ANA result, especially with a **speckled or nucleolar pattern**, supports the diagnosis when considered alongside clinical features.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While imaging studies like **esophageal manometry** or **barium swallow** can show features suggestive of scleroderma (e.g., esophageal dysmotility), they are not as specific or sensitive as ANA testing for making a definitive diagnosis.
- **Option B:** **Rheumatoid Factor (RF)** can be positive in various autoimmune diseases, including rheumatoid arthritis, Sjögren's syndrome, and sometimes scleroderma, but it is not as specific or sensitive as ANA for scleroderma.
- **Option D:** **High-Resolution CT (HRCT) scan** of the chest can reveal features like pulmonary fibrosis, a complication of scleroderma, but it does not directly diagnose the disease.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that while a positive ANA is necessary for the diagnosis of scleroderma, the specificity of ANA for scleroderma increases when certain **subpatterns** are present, such as a **nucleolar pattern**. However, clinical correlation with symptoms and further diagnostic tests (like skin biopsy) may be needed for a definitive diagnosis.

## **Correct Answer:** . Antinuclear Antibody (ANA) test